Cellmid Limited announced that it has made significant progress towards its revenue target of $4 million for the consolidated entity for the year ending 30 June 2016.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.007 AUD | 0.00% | -12.50% | -63.16% |
Mar. 08 | Anagenics Appoints CEO | MT |
Feb. 26 | Anagenics Limited Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-63.16% | 2.16M | |
+14.56% | 396B | |
+13.56% | 142B | |
+18.59% | 77.56B | |
-12.91% | 65.94B | |
-4.32% | 43.2B | |
+6.41% | 35.03B | |
+11.20% | 18.17B | |
+14.49% | 15.96B | |
-3.84% | 11.51B |
- Stock Market
- Equities
- AN1 Stock
- News Anagenics Limited
- Cellmid Limited Provides Consolidated Revenue Guidance for the Year Ending 30 June 2016